Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BRAbank ASA: BRA-ME - Completion of private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Bergen, 10 March 2020 Reference is made to the stock exchange announcement published on 5 March 2020 regarding launch of a private placement in BRAbank ASA ("BRAbank" or the "Company"). BRAbank announces that its Board of Directors has resolved to

Biovica provides updates on FDA application

Uppsala, Sweden, March 10, 2020. Biovica, active in cancer diagnostics, today announced that the company intends to submit an FDA application for market approval of DiviTum in the third quarter of 2020 and not as previously announced in mid-2020.“We are pleased with our results in the analytical validation, which is part of our FDA application and so far meet the criteria we have set. However, a component supplier has had delivery delays which means that we now anticipate being able to submit the FDA application a little later than previously expected,” said Anders Rylander, CEO of Biovica.

Norwegian Minister of Climate and Environment opened upgraded furnace at Elkem Bremanger

10 MARCH 2020: The Norwegian Minister of Climate and Environment, Sveinung Rotevatn, today opened the upgraded silicon furnace at Elkem Bremanger in Norway. The upgrade increases the plant’s cost efficiency and reduces NOx emissions with up to 50% – similar to removing 100.000 diesel cars from the road.Around NOK 250 million has been invested in the upgrade. The Norwegian NOx fund has supported the project with NOK 90 million. In addition to improving cost efficiency and cut NOx emissions, the project has additional benefits, when it comes to safety standards and work environment. “Elkem

Neste to acquire Mahoney Environmental to strengthen its growth strategy and position in renewable raw material sourcing

Neste Corporation, Press Release, 10 March 2020 at 9.55 p.m. (EET)  Neste, the world's leading producer of renewable diesel and sustainable aviation fuel produced from waste and residue raw materials, has agreed to acquire 100% of Mahoney Environmental (Mahoney), a collector and recycler of used cooking oil in the United States, and its affiliated entities. The transaction is subject to the fulfillment of customary closing conditions and regulatory approval. “This is another important step for Neste in the execution of our growth strategy. With this acquisition we will gain

Bong makes bond repurchase

Bong AB (publ) has made a repurchase of its own senior secured notes on the market. The repurchase was made to the nominal amount of SEK 10 million. The repurchase is related to the company’s own bond loan with an outstanding nominal amount before the repurchase of 210 MSEK which Bong issued in October 2018 with a 3 year tenure at the interest rate of Stibor (3m) +10 %. The senior secured notes are listed on Nasdaq Stockholm’s Corporate Bonds List with ISIN: SE0011281419. Bong is one of the leading providers of envelope products in Europe that also offers solutions for distribution

Cereno Scientific Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

Cereno Scientific today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s lead compound CS1, for the treatment of Pulmonary Arterial Hypertension (PAH). PAH is a form of high blood pressure in the lungs where the increased pressure is primarily caused by changes in the lung vessels.CS1 is a reformulation of valproic acid (VPA), an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties. These characteristics are a good match

Clarification of Intrum's exposure in Italy

In light of the Italian government's measures to stem the spread of the corona virus, we anticipate a delay of Intrum's cash flow in Italy. A large proportion of this cash flow is related to secured assets, almost exclusively real estate, that are typically processed through the Italian court system. The absolute majority of Intrum's operations in Italy consists of the partnership with Intesa Sanpaolo, where Intrum owns 51 percent, and a debt portfolio owned through a SPV together with Intesa Sanpaolo, where Intrum owns 41 per cent. The combined contribution in 2019 was approximately 4

Episurf Medical publishes prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE UNITED KINGDOM, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFULThe Board of Directors of Episurf Medical AB (publ) ("Episurf Medical" or "the Company") publishes a prospectus on the basis of the rights issue of shares (the "Rights Issue") resolved by the Extraordinary General Meeting held on March 10, 2020. The prospectus has today been approved and

EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.03.2020

EAB GROUP PLC NOTIFICATION 10.03.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.03.2020   Date 10.03.2020  Exchange transaction Buy  Share class EAB  Amount 496  Average price/share 2.5400 EURHighest price/share 2.5400 EURLowest price/share 2.5400 EURTotal price 1,259.84 EUR      The shares held by EAB Group Plc on 10.03.2020:   EAB 15,931     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken

United Bankers Corporation: Acquisition of Own Shares 10.03.2020

United Bankers Corporation NOTIFICATION   10.03.2020 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 10.03.2020 Date 10.03.2020Exchange transaction BuyShare class UNIAVAmount 300Average price/share 8.7000 EURHighest price/share 8.7000 EURLowest price/share 8.7000 EURTotal price 2,610.00 EUR The shares held by United Bankers Corporation on 10.03.2020: UNIAV 33,587 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

Notification of Trade

Geveran Trading Co. Limited (“Geveran”), a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family, has on 10 March 2020 acquired 135,000 shares in Flex LNG Ltd (“Flex LNG”) at a purchase price of NOK 50.1465 per share. Following the acquisition, Geveran will own 24,678,811 shares in Flex LNG which will constitute 45.61% of the shares and votes in Flex LNG. Geveran controls in addition TRS agreements with exposure to totally 825,000 shares in Flex LNG Ltd. The foregoing calculations are based on 54,110,584 outstanding shares in Flex

Norwegian Energy Company ASA: Share buyback

Reference is made to the stock market announcement on 27 February 2020, where Norwegian Energy Company ASA ("Noreco" or the "Company") announced an initiation of a share buyback programme of up to 160,000 of its own shares. Noreco has on 10 March 2020 purchased 9,992 of its own shares at an average price of NOK 143.3800 per share. After this transaction the Company holds a total of 320,782 own shares. The transaction is completed in accordance with the authorization given by Noreco's annual general meeting on 28 June 2018, which is valid until 28 June 2020. The information is

#20-86 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#20-85 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

SEB’s annual general meeting shortened

Press releaseStockholm  10 March 2020 SEB’s annual general meeting shortened Due to the new coronavirus, SEB has decided to take a number of precautionary measures at the annual general meeting at Konserthuset, Hötorget, Stockholm on 23 March, at 1pm. Registration starts at 11.30. To reduce the risk of infection spread, SEB will shorten the time of the actual AGM and also cancel a number of activities that were previously planned to be held in conjunction with the event. SEB will no longer have an exhibition and won’t offer any food or any informal meetings with the bank’s

Avidly Plc’ Annual Report 2019 has been published

Avidly Plc’ Annual Report 2019 has been published Avidly Plc, Company Announcement 10 March 2020 at 17:15 EET Avidly Plc’ Annual Report 2019 has been published today at https://investors.avidlyagency.com/en/. The Annual Report includes the CEO’s review, the Report of the Board of Directors, the consolidated financial statements, and the auditor’s report. The Annual Report is also attached as a pdf file to this release.  Additional information: Jesse Maula, CEO, Tel. +358 40 548 0248 Hans Parvikoski, CFO, Tel. +358 40 586 6154 Oaklins Merasco Oy acts as Avidly Plc’s

Change of proposal from the Nomination Committee for the Annual General Meeting 2020

On February 28, 2020 the Nomination Committee of HiQ International AB publicly announced its proposal for the Annual General Meeting for: Proposal for Chairman of the Meeting. Proposal for the Chairman of the Board of Directors and members of the Board of Directors. Proposal for compensation to the Board of Directors, distinguishing between the Chairman and other members of the Board and compensation (if any) for committee work. And proposal for company auditor (if needed) and audit fees for the company’s auditor.After the Nomination Committee's proposal was published, Ann Hellenius

Ann Hellenius resigns from HiQ’s Board of Directors

Ann Hellenius, Director of the Board of HiQ International AB, has announced that she will be leaving the company’s Board with immediate effect, and that she will not be at disposal for re-election. The reason is that Ann has accepted an assignment in a to HiQ competing business.“Ann Hellenius has been a member of HiQ’s Board of Directors since 2019 and has through her experience in digitalisation provided valuable knowledge and know-hows to HiQ’s operations. We send thanks for Ann’s commitment to HiQ and wish her all the best for the future”, says Gunnel Duveblad, Chairman of HiQ

Archer Limited: Archer’s Board of Directors appoints Dag Skindlo as CEO and Espen Joranger as CFO of Archer

Hamilton, Bermuda (March 10, 2020) Archer Limited is pleased to announce the appointment of Dag Skindlo as the Company's new Chief Executive Officer. Dag Skindlo joined Archer as Chief Financial Officer and EVP Strategy in May 2016. Kjell-Erik Østdahl, Chairman of Archer, comments: “I’m pleased that Dag will take on this challenge. We have had a thorough recruitment process where the Board has been looking for the best candidate to lead Archer going forward. Dag has a strong commercial track-record and has the best qualifications for delivering on our corporate strategy. He has

Chairman, Vice-Chairman and CMO in Scandion Oncology A/S buy Company shares

Scandion Oncology A/S ("Scandion Oncology" or "the Company") today announces that the Chairman, Vice Chairman and Chief Medical Officer of the Company have bought shares in Scandion Oncology. The shares have been acquired in the daily trading on Spotlight Stock Market.Chairman of the Board Peter Høngaard Andersen has acquired 4,000 shares at a price of 10.85 SEK/share. Vice-Chairman of the board Jørgen Bardenfleth has acquired 26,603 shares at a price of 11.74 SEK/share.   Chief Medical Officer Peter Michael Vestlev has acquired 13,792 shares at a price of 10.63 SEK/share. For

Etteplan’s Annual Report 2019 and Remuneration Policy 2020 have been published

ETTEPLAN OYJ, Stock Exchange Release, March 10, 2020, AT 3.30 P.M. (EET) Etteplan Oyj’s Annual Report for 2019 has been published. The report consists of two parts. Annual Review 2019 covers our strategy and operations. Financial Review 2019 contains the Financial Statements and other investor information. Both reports are attached as PDFs to this release and are also available at https://www.etteplan.com/investors/reports-presentations both in Finnish and English. The Annual Review 2019 will be available in print. Etteplan has also published the Remuneration Policy for the Governing

There are no items matching the current filter
There are no more items matching the current filter
Back to top